Home > PE Ratio > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of FREDUN PHARMACEUTICALS is 25.60.

Share Price ₹1,613.8Mar 16,2026
Market Cap ₹871.5 Cr
Earnings-TTM₹34.0 CrTTM-Standalone Results
Price/Earnings25.60xCalculated as Market Cap/Earnings
Explore Stock Analytics
AD     Remove this Ad
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of FREDUN PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of FREDUN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹871.5 Cr] as on Mar 16,2026

(/) Earnings [ ₹34.0 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 25.60x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for FREDUN PHARMACEUTICALS , the investors are currently willing to pay 25.60 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of FREDUN PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of FREDUN PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of FREDUN PHARMACEUTICALS


PE Ratio Performance Analysis for FREDUN PHARMACEUTICALS

- FREDUN PHARMACEUTICALS 's latest p/e ratio is 25.60x.

- FREDUN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 45.03x.

- FREDUN PHARMACEUTICALS 's operated at median p/e ratio of 32.6x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, FREDUN PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 91.79x.

- FREDUN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2025 of 15.17x.


How does FREDUN PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
FREDUN PHARMACEUTICALS 34.0525.60871.5
SUN PHARMACEUTICAL INDUSTRIES LTD11,001.4038.88427,693.0
DIVIS LABORATORIES LTD2,479.0065.05161,270.0
CIPLA LTD4,544.7023.09104,915.0
TORRENT PHARMACEUTICALS LTD2,272.0063.50144,281.0
DR REDDYS LABORATORIES LTD5,508.7019.32106,422.0
MANKIND PHARMA LTD1,796.6548.0686,354.7
ZYDUS LIFESCIENCES LTD4,933.9018.0889,182.5
LUPIN LTD4,669.1822.42104,670.0
AUROBINDO PHARMA LTD3,513.2021.1574,304.9
ABBOTT INDIA LTD1,524.1337.2056,690.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs FREDUN PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.08x
Max industry PE 65.05x
Median industry PE 25.60x
Average industry PE 34.76x



You may also like the below Video Courses